Radical Prostatectomy Sept 2009 till Aug 2010 South Mersey Cancer Network Manal Kumar Consultant Urologist.

Slides:



Advertisements
Similar presentations
HELIOS Kliniken Leipziger Land Folie: 1 K. Kuhnt D. Schulz NESA DAYS 2006 Positive margins and early postop potency after Nerve-sparing ELRP Kai Kuhnt.
Advertisements

50 Vs 50 A Comparison of the Oncologic Outcomes of Retropubic Prostatectomy and Robotic Prostatectomy Chris Ogden Tim Christmas Jordan Durrant Khalid A.
 Radical Laparoscopic Prostatectomy: Managing Localized Prostate Cancer Chase Wilson M1.
PROSTATE CANCER da Vinci Robot Surgery Cedric Emery, MD. FACS
NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Cases in Urological Oncology Dr Manish Patel MB.BS., MMed., FRACS, PhD Urological Cancer Surgeon Westmead Public and Private Hospital Westmead Public and.
The Delivery of Radical Prostatectomy to Treat Men With Prostate Cancer ChartbookAugust 2014.
THE CLINICO-PATHOLOGIC PATTERNS OF PROSTATIC DISEASES AND PROSTATE CANCER IN SAUDI PATIENTS Hisham A. M. Mosli, FRCSC, FACS Taha A. Abdel-Meguid, MD Jaudah.
Experience of Radical Robotic Prostatectomy using the DaVinci S Robot in Localised Prostate Cancer Rashid TG, Dudderidge T, Zahur S, Kini M, Jameson C,
EXTRAPERITONEAL RADICAL PROSTATECTOMY AND PREVIOUS HISTORY OF HERNIA REPAIR: EVALUATION OF RESULTS SELCUK KESKIN, GUILLAUME GUICHARD, ÁNDRAS HOZNEK, ALEXANDRE.
Radical Prostatectomy: A Critical Analysis of Surgical Quality Between the Open and Laparoscopic Approaches. Karim Touijer, MD.
WHICH NEPHRECTOMY. laparoscopic nephrectomy Simple laparoscopic nephrectomy. Donor laparoscopic nephrectomy. Radical laparoscopic nephrectomy. Partial.
Mr Jonathan Lewin MBBS, MRCS, MD, FRCS(Urol), FRACS Consultant Uro-Oncological Surgeon.
Robotic Assisted Surgery
PROSTATE CANCER EXPECTED MANAGEMENT & CURATIVE TREATMENT Dr. Abdullah A. Ghazi (R5) KSMC.
Prostate Radiotherapy A-Z
PROSTATE CANCER LETS DEBATE !!!! Dr Fred C Tyler MBChB FRCS FCS UROL.
Everything you need to know about Prostate Radiotherapy During the talk or at end send QUESTIONS: Rob.
Treatment options for locally recurrent Prostate Cancer Giuseppe Simone Mediterranean School of Oncology Roma
Prof Stephen Langley Professor of Urology St Luke’s Cancer Centre, Guildford, UK PGMS, University of Surrey Focal Brachytherapy UK experience.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Updated 5-year Biochemical Relapse-Free Survival after Prostate Brachytherapy Jenny P. Nobes St. Luke’s Cancer Centre, The Royal Surrey County Hospital,
Advances in Robotic Surgery:
Laparoscopic Radical Prostatectomy: Oncological and Functional Outcomes Following Fellowship Training. Introduction Radical Prostatectomy (RP) is a technically.
Rashid TG, Dudderidge T, Zahur S, Kini M, Ogden CW.
Introducing a new and simple scoring system to evaluate oncological and functional outcome after radical prostatectomy Salomon L., De La Taille A., Vordos.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
Oncology 11 Localised Prostate Cancer VIVA
Dr. Abdullah Ahmad Ghazi (R5) KSMC  Estimated as:  5-69% of women  1-39% of men.
Val Ward Caroline Grimes Clinical Nurse Specialist: Rochester.
Trends in prostate cancer and its management in the South West Region, Hampshire and the Isle of Wight Christine Harling Julia Verne (SWPHO) Roy Maxwell.
Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.
Robot-assisted Laparoscopic Radical Cystectomy KH Rha Severance Hospital Yonsei University The 10 th Catholic International Urology Symposium, :30–14:50.
IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC.
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
Urology and male health
Robotic-assisted Laparoscopic Prostatectomy
Network meeting Taunton Rugby club January 20th
International Neurourology Journal 2015;19:
Volume 155, Issue 3, Pages (March 1996)
Philipp Dahm, Ari D. Silverstein, Alon Z
Surgical Treatment in Locally Advanced Prostate Cancer
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital
Bladder Cancer and Prostatic Cancer
J. Edson PontesM.D. Professor Urologic Oncology WSU/KCI
FACTORS RELATED WITH URINARY INCONTINENCE GRADE AFTER RADICAL PROSTATECTOMY Padilla Fernández, B.1; Virseda Rodríguez, ÁJ2; Pereira, BJ3, Coelho, H4,;
Is Brachytherapy 125I still needed in Prostate cancer treatment?
Post Op Positive Apex Margins Case 3: Prostate_3
Nat. Rev. Urol. doi: /nrurol
New perioperative risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience in high volume Canadian.
2327 PROSTATE CANCER STAGE, GRADE AND POSITIVE MARGIN RATE IN MEN WITH PSA ≥ 1 ng/ml UNDERGOING RADICAL PROSTATECTOMY: POPULATION DATA ANALYSIS  Sergey.
RELAZIONE TRA “STAGE MIGRATION” E
Laparoscopic Radical prostatectomy: Is it still a treament of choice?
Post Op Positive Seminal Vesicle Case 4: Prostate_4
Prostate Cancer: Highlights from 2006
ROBOTIC ASSISSTED RADICAL PROSTATECTOMY OUR INITIAL EXPERIENCE
Apollo Gleneagles Hospitals,
Volume 52, Issue 1, Pages (July 2007)
Volume 62, Issue 2, Pages (August 2012)
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
EARLY AND LATE COMPLICATIONS OF PROSTATE LOW DOSE BRACHYTHERAPY
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Antonio Galfano, Silvia Secco, Aldo Massimo Bocciardi  European Urology 
Antonio Alcaraz, Pierre Teillac  European Urology Supplements 
Prostate Cancer Update
Management of Prostate Cancer: Global Strategies
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Surgery for high-risk prostate cancer: The results of first 80 cases
Presentation transcript:

Radical Prostatectomy Sept 2009 till Aug 2010 South Mersey Cancer Network Manal Kumar Consultant Urologist

Radical Prostatectomy 80 patients 17 open (1/16) – 42 to 73 yrs (63 yrs) 63 laparoscopic – 44 to 74 yrs (63 yrs) – Two patients did not undergo lap prostatectomy Extensive adhesions Incidental bladder tumour

Pre op PSA Open – 4.2 to 18.8ng/ml(9.5ng/ml) Lap RP – 0.8 to 29.7 ng/ml (8.5ng/ml)

Patient Selection All risk categories Previous operations TURPs, inguinal and para-umbilical hernia appendicectomy BMI up to 38 Prostate volume 18 to 150 cc

Pre op Staging

Pre op Gleason Score

Risk Category

Lymphnode Dissection

Nerve Sparing Prostatectomy

OP Time Open RRP – 120 to 220 min (182 min) Lap RP – 150 to 270 min (201 min)

OP Time

Blood Loss Open RRP – 500 ml to 3000 ml (1400ml) – Data was not recorded for 10 patients – One patient had blood transfusion Lap RP – 50 to 1000 ml (265 ml) – No blood transfusion

Laparoscopic Prostatectomy Complications One (1.6%) incisional hernia (Clavien 3b) One (1.6%) lymphocele (Clavien 3a) One (1.6%) peno- bulbar stricture (Clavien 3a) One blocked catheter (Clavien 1) One patient had mild haematuria (Clavien 1) No transfusion, no ileus and no conversion to open surgery No anastamotic strictures

Length of Stay Open prostatectomy – 3 to 8 days (5.9 days) Lap prostates – 2-6 days (2.3 days) – All except two patients were discharged within 3 days

Positive Surgical Margins Overall 26/71 (36%) Open – 7/14 (50%) – 6 T3a Laparoscopic prostatectomy – 19/57 (33%) – 8 T3a – 3 T3b – Only one bladder neck positive

Post Operative PSA PSA <0.1ng/ml94% Only 4 (6%) of LRP patients have PSA above 0.1% Two of these patients had T3b disease and three of the four have Gleason 4+4 disease 13/14 (92%) open prostatectomy patients had PSA <0.1 ng/ml

Continence 50 patients with > 3 mths follow up Four (8%) wearing more than one pad a day 2/12 open prostatectomy patients wearing more than one pad a day

Acknowledgement Gill Riley